Glycoproteinosis

From WikiMD's WELLNESSPEDIA


Glycoproteinosis
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, organomegaly, skeletal abnormalities, neurological symptoms
Complications
Onset Infancy or early childhood
Duration
Types Mucolipidosis, Mannosidosis, Fucosidosis, Sialidosis
Causes Genetic mutation
Risks
Diagnosis Genetic testing, enzyme assay
Differential diagnosis Lysosomal storage disorders
Prevention
Treatment Supportive care, enzyme replacement therapy
Medication
Prognosis Variable, depending on type
Frequency Rare
Deaths


Glycoproteinosis is a rare metabolic disorder characterized by the accumulation of glycoproteins in the body's tissues. This condition is caused by a deficiency in the enzymes needed to break down these complex sugars.

Symptoms[edit]

The symptoms of glycoproteinosis can vary widely, but often include neurological problems, organomegaly (enlarged organs), and skeletal abnormalities. Other symptoms may include developmental delay, intellectual disability, and seizures.

Causes[edit]

Glycoproteinosis is caused by mutations in various genes that encode for enzymes involved in the breakdown of glycoproteins. These mutations lead to a deficiency in these enzymes, causing glycoproteins to accumulate in the body's tissues.

Diagnosis[edit]

Diagnosis of glycoproteinosis is typically made through a combination of clinical examination, genetic testing, and biochemical testing. This may include measuring the levels of specific enzymes in the blood or other body fluids, or analyzing the structure of glycoproteins in the body.

Treatment[edit]

There is currently no cure for glycoproteinosis. Treatment is typically supportive and aimed at managing the symptoms of the disease. This may include physical therapy for mobility issues, medication for seizures, and other interventions as needed.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.